NCT05735743

MoVE Trial: Motivational Strategies to Empower African Americans to Improve Dialysis Adherence

MoVE Trial: Motivational Strategies To Empower African Americans To Improve Dialysis Adherence

• Status: Active Not Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 176 (actual)
• Sponsor: Vanderbilt University Medical Center · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

MoVE Trial is a randomized clinical trial designed to rigorously test the impact of a behavioral intervention (culturally tailored motivational interviewing - (MOVE)) delivered by trained health coaches, on hemodialysis treatment non-adherence. It is a a two-arm, parallel group randomized clinical trial with 24-week follow-up. It involves completion of surveys by patients enrolled in the study. It also involves participation in motivational interviewing sessions by patients who are randomized to the intervention (MI).

Conditions

• End Stage Renal Disease on Dialysis

Interventions

Type	Name	Description
BEHAVIORAL	Motivational interviewing	In this trial, motivational interviewing (MI) is the intervention. The MI sessions will embody the spirit of MI (PACE - Partnership, Acceptance, Compassion and Evocation) and the use of MI strategies (OARS - Open-ended questions, Affirmations, Reflections and Summaries) and MI communication processes (engagement, focusing, evoking and planning).

Timeline

• Start date: 2023-10-09
• Primary completion: 2027-11-01
• Completion: 2027-11-01
• First posted: 2023-02-21
• Last updated: 2026-04-16

Locations

6 sites across 1 country: United States